HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ohad Mazor Selected Research

Bacteriochlorophylls

7/2005Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins.
3/2005WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model.
10/2004Homologous adaptation to oxidative stress induced by the photosensitized Pd-bacteriochlorophyll derivative (WST11) in cultured endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ohad Mazor Research Topics

Disease

9COVID-19
11/2021 - 01/2020
5Infections
02/2022 - 01/2019
5Neoplasms (Cancer)
06/2018 - 11/2003
4Poisoning
04/2020 - 09/2006
2Inflammation (Inflammations)
09/2015 - 01/2014
2Pain (Aches)
04/2007 - 09/2006
2Melanoma (Melanoma, Malignant)
07/2005 - 03/2005
2Phototoxic Dermatitis (Phototoxicity)
07/2005 - 03/2005
1Paralysis (Palsy)
03/2022
1Body Weight (Weight, Body)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Acute Lung Injury
01/2021
1Neoplasm Metastasis (Metastasis)
06/2018
1Breast Neoplasms (Breast Cancer)
06/2018
1Botulism
12/2017
1Lung Injury
10/2017
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2017
1Edema (Dropsy)
10/2017
1Tularemia
01/2016
1Bacteremia
05/2014
1Respiratory Insufficiency (Respiratory Failure)
01/2014
1Anthrax
07/2009
1Photosensitivity Disorders (Photodermatitis)
10/2004
1Hypoxia (Hypoxemia)
10/2004
1Carcinoma (Carcinomatosis)
11/2003
1Necrosis
11/2003
1Colonic Neoplasms (Colon Cancer)
02/2002
1Carcinoid Tumor (Carcinoid)
02/2002

Drug/Important Bio-Agent (IBA)

5Monoclonal AntibodiesIBA
11/2021 - 01/2020
5AntibodiesIBA
11/2021 - 05/2014
5RicinIBA
01/2021 - 01/2014
4Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2004
4Neutralizing AntibodiesIBA
11/2021 - 07/2009
3EpitopesIBA
02/2022 - 04/2007
3AntigensIBA
10/2021 - 07/2009
3AbrinIBA
04/2020 - 09/2015
3padeliporfinIBA
07/2005 - 10/2004
3BacteriochlorophyllsIBA
07/2005 - 10/2004
2Angiotensin-Converting Enzyme 2IBA
01/2021 - 01/2021
2VaccinesIBA
12/2020 - 04/2020
2CytokinesIBA
06/2018 - 10/2017
2AntitoxinsIBA
12/2017 - 10/2017
1botulinum toxin type EIBA
03/2022
1Immunoglobulin A (IgA)IBA
10/2021
1Viral AntigensIBA
10/2021
1Immunoglobulin M (IgM)IBA
10/2021
1Immunoglobulin G (IgG)IBA
10/2021
1Subgenomic RNAIBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
06/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2018
1Interleukin-17 (Interleukin 17)IBA
06/2018
1Immunomodulating AgentsIBA
10/2017
1Doxycycline (Periostat)FDA LinkGeneric
01/2014
1SomanIBA
04/2007
1Amino AcidsFDA Link
04/2007
1EnzymesIBA
04/2007
1Cholinesterases (Cholinesterase)IBA
09/2006
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2006
1Blood Proteins (Serum Proteins)IBA
07/2005
1Serum AlbuminIBA
03/2005
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2004
1palladium-bacteriopheophorbideIBA
11/2003
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2003
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2003
1Pharmaceutical PreparationsIBA
11/2003
1Epidermal Growth Factor (EGF)IBA
02/2002

Therapy/Procedure

8Therapeutics
05/2021 - 11/2003
3Photochemotherapy (Photodynamic Therapy)
07/2005 - 11/2003
1Drug Therapy (Chemotherapy)
11/2003